ArticleCurrent microbiology2025
Quorum-sensing Inhibitory Activity of Xanthones from Hypericum Curvisepalum N. Robson Against Chromobacterium Violaceum.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, bacterial drug resistance has increased alarmingly. The scarcity of novel antibiotics and few available drug targets significantly contribute to rising drug resistance. Searching quorum-sensing interfering agents and biofilm formation inhibitors are the most promising approaches for fighting multi-drug resistant bacterial infections. Chinese herbal medicines represent a rich repository for discovering quorum sensing (QS) inhibitors. In a continuation of the search for QS inhibitors from plants of Hypericum, significant bioactivity was observed in the ethyl acetate extract of Hypericum curvisepalum. Twelve known xanthones were obtained from this extract through bioassay-guided fractionation and subsequent identification (1-12), together with an undescribed analogue (16), two chromone derivatives (13 and 14), and a flavonoid (15). Compounds 2, 3, 6, and 7 showed apparent anti-quorum sensing activity against Chromobacterium violaceum ATCC12472 with violacein inhibition rates of 91.2, 90.6, 88.3, and 83.0% at 250 μM. In addition, compounds 2, 3, 6, and 7 also suppressed the motility and significantly reduced the biofilm formation of C. violaceum ATCC12472. Molecular docking analyses, Isothermal titration calorimetry (ITC) and qRT-PCR experiments suggested that these four compounds could bind with CviR receptor and downregulated genes vioB, vioC, and vioD encoding to regulate violacein biosynthesis. Xanthones from Hypericum could be considered as an important source of natural QS inhibitors towards C. violaceum ATCC12472.
Indexed as
Identifiers
40760352What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.